Nov 15, 2022 Clinical Trials and Privacy Matters: A Cross-border Guide By Marco de Morpurgo This week our Life Sciences team published the first edition of its Cross-border Guide to Clinical Trials and Privacy. The Guide will...
Mar 24, 2023 Inspirational Women in Life Sciences Series - an interview with Lyndsey Hudson By Lyndsey Hudson Mary Foord-Weston In the second of our Cortex series on Inspirational Women in Life Sciences, we are proud to feature DLA Piper’s very own Dr Lyndsey...
Mar 20, 2023 Extended transition period gives medical device industry extra time to comply with EU MDR By Marco de Morpurgo Nicola Landolfi A much-awaited extension of the MDR transition period became effective today with the publication of Regulation (EU) 2023/607 in the...
Mar 17, 2023 FDA calls for comments on artificial intelligence in drug manufacturing By Keo Shaw Bethany Hills Daniel Tobey Geoffrey Levitt +1 more... Show less On March 1, 2023, FDA’s Center for Drug Evaluation and Research (CDER) published a discussion paper on artificial intelligence (AI) in...
Mar 14, 2023 Advertising therapeutic goods in Australia (don't let your ad make you sad) By Nicholas Tyacke Greg Bodulovic Alexandra de Zwart Due to a complex array of legislation, regulations and codes, advertising therapeutic goods in compliance with Australian law can be a...
Mar 10, 2023 Poland - Life Sciences monthly brief, February 2023 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our January monthly briefing, which covers key updates and insights in the following areas: Medicinal productsClinical...
Mar 08, 2023 Inspirational women in life sciences series – International Women’s Day By Mary Foord-Weston Beginning on International Women’s Day (IWD), DLA Piper’s Cortex blog is running a series with inspirational guest speakers to celebrate...
Feb 15, 2023 Italy: Privacy and data protection considerations for establishing and implementing eHealth databases By Cristina Criscuoli Please note: this article was first published in One Trust here. Since 2022, the Government of Italy ('the Government') has been working...
Feb 09, 2023 Portugal: A transformation of the healthcare system may be under way By Mariana Ricardo Pharmacies have always played a relevant role in healthcare in Portugal, where pharmacists and pharmacy technicians traditionally share...
Feb 08, 2023 Neglected Tropical Diseases – Progress report highlights accomplishments and challenges By Ana Rita Santos On occasion of the World Neglected Tropical Diseases Day 2023, on January 30, the World Health Organization (WHO) published the Global...
Feb 07, 2023 World-first: Australia to approve psilocybin and MDMA for the treatment of certain mental health conditions By Greg Bodulovic Nicholas Tyacke Tudor Filaret Australia is the first country in the world to legalise the prescription of psilocybin and MDMA to assist in the treatment of certain...
Feb 06, 2023 Poland - Life Sciences Monthly Brief, January 2023 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our January monthly briefing, which covers key updates and insights in the following areas: Pharmacies; Clinical...
Feb 06, 2023 Clinical trials in the EU: mandatory CTIS procedures and new transparency requirements from 31 January 2023 By Marco de Morpurgo Nicola Landolfi On 31 January 2023, the new Clinical Trials Information System (CTIS) established by Regulation (EU) 536/2014 on clinical trials (CTR)...
Feb 01, 2023 Working on the affordability of medicines: 2023 begins with an important message on excessive pricing - Portugal By Mariana Ricardo Early this year, the Portuguese Minister of Health stated the public expense with medicines in 2022 showed an increase of more than EUR...
Jan 30, 2023 Swedish government proposes fines between SEK 25k - 100m (approx. EUR 2,500 – 10 million) for late backorders by pharmaceutical companies By Fredrika Allard The Swedish government has on 24 January 2023 proposed a bill with actions aimed at improving the availability of medicines. The bill...
Jan 23, 2023 Pharmaceutical and medical sector in Poland, DLA Piper Report By Andrzej Balicki, Ph.D. Jolanta Dabrowicz We would like to invite you to read our report summarising the second edition of the DLA Piper survey "Pharmaceutical and medical sector...
Jan 19, 2023 What is the projected – and much anticipated – key pillar for the health sector in Brazil in 2023? By Bruna Rocha Juliana Marcondes Victoria Cristofaro During the World Economic Forum 2023 in Davos, specialists discussing the topic of health unanimously indicated that “the past three...